Counselors in Cambridge, MD Accepting Medicare

22 Counselors found. Showing 1 - 20

Lori Joy Price, LCPC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 708 Church St, Cambridge, MD 21613 Phone: 437-605-3204

Audrey Parker-balthaser, CAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 828 Airpax Rd, Bldg B Ste 300, Cambridge, MD 21613 Phone: 410-228-3929    Fax: 410-228-3810

Aja Asparagus, LGPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 332 Appleby School Rd, Cambridge, MD 21613 Phone: 484-983-5942

Carol M Asplen-masden, LCSW-C Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 100 Bramble St, Cambridge, MD 21613 Phone: 410-901-2000    Fax: 410-901-8313

Tina Carter, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 426 Dorchester Ave, Cambridge, MD 21613 Phone: 410-228-3929    Fax: 410-228-3810

Latrell Williams-elliott, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 403 High St, Cambridge, MD 21613 Phone: 443-225-5780

Mark E Modoski, LCSW-C Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2700 Willow Oak Dr Apt 112, Cambridge, MD 21613 Phone: 443-521-9525

Dean Evans Counselor - Pastoral Medicare: Not Enrolled in Medicare Practice Location: 1006 Phillips St, Cambridge, MD 21613 Phone: 410-603-7570

Andrea Lynn Minerva, LGPC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 502 Poplar St, Cambridge, MD 21613 Phone: 443-225-5780

Ms. Sonya M Mckee, LCSW-C, CAC-AD Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 828 Airpax Rd, Cambridge, MD 21613 Phone: 410-548-3333

Mrs. Phyllis T. Cook, CAC-AD, CCDC, ICADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2823 Ocean Gtwy, Cambridge, MD 21613 Phone: 410-221-6343    Fax: 410-221-6342

Omeaka Jackson Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 204 Cedar St, Ste 102, Cambridge, MD 21613 Phone: 301-728-3857

Willard Rogers Counselor Medicare: Not Enrolled in Medicare Practice Location: 408 Maryland Ave, Cambridge, MD 21613 Phone: 301-500-5224

Mr. Gerald Lee Beemer, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 813-1 Chesapeake Drive, Cambridge, MD 21613 Phone: 410-221-2266    Fax: 410-221-2878

Ms. Shelia Yvonne Kroon, CSC-AD Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 828 Airpax Rd, Bldg B Ste 300, Cambridge, MD 21613 Phone: 410-228-3929    Fax: 410-228-3810

Jacqueline Sorrells, LGPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 204 Cedar St Ste 102, Cambridge, MD 21613 Phone: 443-351-4846

Mrs. Jessica L Ives, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 3 Cedar St, Cambridge, MD 21613 Phone: 443-477-3589    Fax: 410-228-0513

Trudy Adkins Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 828 Airpax Rd, Cambridge, MD 21613 Phone: 410-901-1333

Mrs. Shana Leigh Morgan, ADT Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 403 High St, Cambridge, MD 21613 Phone: 443-225-5780    Fax: 443-225-5783

Jeff Biele, LCPC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 300 Byrn St, Cambridge, MD 21613 Phone: 410-228-5511    Fax: 410-901-2764

News Archive

FDA approval for Diovan (Valsartan)

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Diovan (valsartan), the most prescribed ARB (angiotensin receptor blocker) in the US and worldwide, for a new indication to reduce cardiovascular death in patients at high risk (with left ventricular failure or left ventricular dysfunction) following a heart attack.

Effects of estrogen on heart disease prevention

Researchers at Yale School of Medicine and seven other national institutions are recruiting patients to participate in the Kronos Early Estrogen Prevention Study (KEEPS) to look at the effects of estrogen on heart disease prevention.

The Endocrine Society urges NIH to increase funding for stem cell research

Stem cell research holds great promise for the treatment of millions of Americans with debilitating and possibly fatal diseases. Current legislation and guidelines, however, continue to limit researchers' endeavors in unlocking the potential breakthroughs that stem cell research can provide. To address this concern, today The Endocrine Society issued a Position Statement (http://www.endo-society.org/advocacy/policy) calling for an increase in NIH funding for stem cell research as well as expanding the scope of funding to include promising yet neglected areas of stem cell research.

Optiquant BKV Quantification Panel for MSSA DNA testing procedures

AcroMetrix, a leading provider of quality control standards for clinical diagnostic laboratories, announced today the launch of the first standardized quality control for MSSA molecular testing.

18F-FGD-PET measures predict mRCC TKI response

Positron emission tomography could be used to predict the response of metastatic renal cell carcinoma to tyrosine kinase inhibitor therapy within a couple of weeks of a patient beginning treatment, research suggests.

Read more Medical News

› Verified 3 days ago

• 1(current)
• 2